Product image of Eribulin Medac (Eribulin) supplied by GNH India

Eribulin Medac

Active Ingredient:
Eribulin
Origin:
EU

Eribulin Medac (Eribulin)

Eribulin Medac is a pharmaceutical product used in cancer treatment. This intravenous medication is designed to target and disrupt cancer cell division, offering a therapeutic option for certain types of cancer.

Manufacturer / TM Owner

Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Eribulin Medac is primarily used in the treatment of advanced breast cancer. It works by interfering with the growth and spread of cancer cells, making it a valuable option for patients who have limited treatment alternatives. The medication is administered intravenously, allowing it to enter the bloodstream directly.

Side Effects

  • Common effects of Eribulin Medac may include fatigue, nausea, and hair loss. Some patients may also experience peripheral neuropathy, which can cause numbness or tingling in the hands and feet. These effects vary among individuals and should be discussed with a healthcare provider.

Precautions & Warnings

  • Eribulin Medac should be handled with care and administered under the supervision of a healthcare professional. It is important to follow the prescribed dosage and administration schedule to minimize potential risks. Patients should inform their healthcare provider about any existing medical conditions or medications they are taking.

Avoid Interactions

  • Eribulin Medac may interact with other medications, including those that affect liver function or blood cell production. It is crucial to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be discussed with your healthcare provider.

Frequently Asked Questions

Eribulin Medac is used in the treatment of advanced breast cancer, particularly in patients who have limited treatment options.

Eribulin Medac is administered intravenously, meaning it is delivered directly into the bloodstream through a vein.

Common side effects may include fatigue, nausea, hair loss, and peripheral neuropathy, which can cause numbness or tingling in the hands and feet.

Eribulin Medac may interact with other medications, so it is important to inform your healthcare provider about all medications you are taking.

Eribulin Medac should be administered under the supervision of a healthcare professional, and patients should follow the prescribed dosage and administration schedule.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Eribulin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT